DISCOVERY

From antigen definition to first R&D batch production in less than five months

Our approach on RNA-based therapeutics research

We work with mRNA vaccine and therapeutic developers early on in the discovery process to provide essential skills such as antigen definition, construct design and optimization, as well as high-throughput milligrams scale non-GMP production to support research and preclinical development to achieve viable and manufacturable RNA drug candidates.

We offer access to the right tools, process, and production systems to accelerate your RNA therapeutic’s development. In addition, our discovery processes are designed specifically to scale up seamlessly to production volumes using the same technology. This fast-tracks commercialization with limited investment cost. Finally, our tailored program fits your needs whether it is support for the whole discovery workflow or for just parts of it.

Exothera team members supporting a customer in its mRNA discovery process

Our approach

We work with mRNA vaccine and therapeutic developers early on in the discovery process to provide essential skills such as antigen definition, construct design and optimization, as well as high-throughput milligrams scale non-GMP production to support research and preclinical development to achieve viable and manufacturable RNA drug candidates.

We offer access to the right tools, process, and production systems to accelerate your RNA therapeutic’s development. In addition, our discovery processes are designed specifically to scale up seamlessly to production volumes using the same technology. This fast-tracks commercialization with limited investment cost. Finally, our tailored program fits your needs whether it is support for the whole discovery workflow or for just parts of it.

Nucleic Acid Discovery Development Process Flow

Nucleic acids-based products discovery process workflow

For any additional information

Please contact us and we will respond quickly!

Contact us